Aims and Scope of Pharmacological Reviews
Pharmacological Reviews is a quarterly peer-reviewed scientific journal publishing review articles on all aspects of pharmacology and related topics. It is published by the American Society for Pharmacology and Experimental Therapeutics. The editor-in-chief is David R. Sibley (National Institute of Neurological Disorders and Stroke). Less
Key Metrics
CiteScore 

35.4
Eigenfactor 

0.005 - 0.01
Impact Factor 

20 - 25
SJR 

Q1Pharmacology

SNIP 

6.44
Recommended pre-submission checks
Powered by 

Topics Covered on Pharmacological Reviews
Pharmacological Reviews Journal Specifications
| Overview | |
| Publisher | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1949 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmacological Reviews ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Pharmacological Reviews
Edaravone: Advances on cytoprotective effects, pharmacological properties, and mechanisms of action.
- 1 Jan 2026
- Pharmacological reviews
MiR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response.
- 1 Jan 2026
- Pharmacological reviews
Platelet activation, aspirin, and cancer: From basic science to clinical trials.
- 1 Jan 2026
- Pharmacological reviews
Modeling lung transporters and their influence on inhaled drug disposition.
- 1 Jan 2026
- Pharmacological reviews
Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment-A scoping review.
- 1 Jan 2026
- Pharmacological reviews
Computational drug design in the artificial intelligence era: A systematic review of molecular representations, generative architectures, and performance assessment.
- 1 Jan 2026
- Pharmacological reviews
Edaravone: Advances on cytoprotective effects, pharmacological properties, and mechanisms of action.
- 1 Jan 2026
- Pharmacological reviews
MiR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response.
- 1 Jan 2026
- Pharmacological reviews
Platelet activation, aspirin, and cancer: From basic science to clinical trials.
- 1 Jan 2026
- Pharmacological reviews
Modeling lung transporters and their influence on inhaled drug disposition.
- 1 Jan 2026
- Pharmacological reviews
Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment-A scoping review.
- 1 Jan 2026
- Pharmacological reviews
Computational drug design in the artificial intelligence era: A systematic review of molecular representations, generative architectures, and performance assessment.
- 1 Jan 2026
- Pharmacological reviews